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Acanthamoeba castellanii Genotype T4 Stimulates the Production of
Interleukin-10 as Well as Proinflammatory Cytokines in THP-1 Cells,
Human Peripheral Blood Mononuclear Cells, and Human Monocyte-
Derived Macrophages
Antonella Mattana,a Manuela Sanna,a Antonella Cano,a,b Giuseppe Delogu,a Giuseppe Erre,a Craig W. Roberts,b Fiona L. Henriquez,c
Pier Luigi Fiori,a Piero Cappuccinellia
Department of Biomedical Sciences, University of Sassari, Sassari, Italya; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow,
United Kingdomb; IBEHR, School of Science & Sport, University of the West of Scotland, Paisley, United Kingdomc
Free-living amoebae of the genus Acanthamoeba can cause severe and chronic infections in humans, mainly localized in immune
privileged sites, such as the brain and the eye. Monocytes/macrophages are thought to be involved in Acanthamoeba infections,
but little is known about how these facultative parasites influence their functions. The aim of this work was to investigate the
effects of Acanthamoeba on human monocytes/macrophages during the early phase of infection. Here, THP-1 cells, primary hu-
man monocytes isolated from peripheral blood, and human monocyte-derived macrophages were either coincubated with tro-
phozoites of a clinical isolate of Acanthamoeba (genotype T4) or stimulated with amoeba-derived cell-free conditioned medium.
Production of proinflammatory cytokines (tumor necrosis factor alpha [TNF-], interleukin-6 [IL-6], and IL-12), anti-inflam-
matory cytokine (IL-10), and chemokine (IL-8) was evaluated at specific hours poststimulation (ranging from 1.5 h to 23 h). We
showed that both Acanthamoeba trophozoites and soluble amoebic products induce an early anti-inflammatory monocyte-mac-
rophage phenotype, characterized by significant production of IL-10; furthermore, challenge with either trophozoites or their
soluble metabolites stimulate both proinflammatory cytokines and chemokine production, suggesting that this protozoan infec-
tion results from the early induction of coexisting, opposed immune responses. Results reported in this paper confirm that the
production of proinflammatory cytokines and chemokines by monocytes and macrophages can play a role in the development of
the inflammatory response during Acanthamoeba infections. Furthermore, we demonstrate for the first time that Acanthamoeba
stimulates IL-10 production in human innate immune cells, which might both promote the immune evasion of Acanthamoeba
and limit the induced inflammatory response.
Ubiquitous amoebae of the genus Acanthamoeba are am-phizoic protozoa with the ability to exist both as free-living
organisms in nature and as parasites within host tissues (1). Nu-
merous reports indicate that several species of Acanthamoeba can
infect humans, producing severe ocular disease and almost invari-
ably fatal neurological disease (2–7). Human infections are gener-
ally site specific: corneal and neural tissues are the primary targets,
although other tissues can be affected. Acanthamoeba can act as
opportunistic as well as nonopportunistic pathogens.
In immunocompromised patients, Acanthamoeba cause an in-
tense, progressive, chronic, often fatal granulomatous amoebic
meningoencephalitis, GAE, as well as lesions within eye, skin,
lungs, and bones. More recently, GAE also has been reported in
healthy individuals (3, 8–11). In some cases, these apparently im-
munocompetent GAE patients had a history of exposed skin le-
sions, chronic sinusitis, rhinitis, or pneumonia (12), suggesting
that Acanthamoeba can reach the central nervous system through
three main portals of entry: skin lesions, the respiratory tract, and
the olfactory neuroepithelium.
In immunocompetent individuals, Acanthamoeba are agents
of a painful, progressive, sight-threatening corneal infection,
termed Acanthamoeba keratitis (AK). The corneal epithelium is
primarily affected with evident inflammation; however, infection
can progress within the deeper layers and, if not promptly diag-
nosed, can lead to partial or complete loss of vision. AK is mainly
associated with use of contact lenses (CLs). This is for a number of
reasons, including the ability of CLs to cause microcorneal
trauma, and their inappropriate use, maintenance, and cleaning
can facilitate their contamination with Acanthamoeba (13).
Understanding the pathogenesis of disease, including the com-
plexity of the immunological mechanisms involved, is essential
for the development of effective prophylactic and therapeutic
strategies. Host resistance mechanisms operative against Acan-
thamoeba may involve innate and acquired immunity. The initial
innate immune response and the formation of granulomas in the
brain and other tissues are presumed to be essential events for
impeding the invasion and dissemination of Acanthamoeba tro-
phozoites (14).
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Many studies have indicated that macrophages are important
effectors in the granulomatous reaction surrounding infected tis-
sues (15). In addition, it has been reported that the elimination of
conjunctival-corneal macrophages in vivo results in a severe pro-
longed course of Acanthamoeba keratitis without resolution (16).
A study on amoeba-macrophage interactions has also established
that activated macrophages can injure weakly pathogenic species
ofAcanthamoeba, whereas highly pathogenic species can evade the
microbicidal activity of these effector cells (17). Nevertheless, very
little is known about the biochemical mechanisms that occur in
humanmonocytes upon exposure to Acanthamoeba trophozoites
or their products.
Cells of the monocyte/macrophage lineage can modulate the
immune response to microbes and microbial products by both
the induction of membrane-associated signaling molecules and
the synthesis and secretion of soluble cytokines. Upon microbial
recognition, activatedmonocytes/macrophages can release a wide
range of proinflammatory cytokines, such as tumor necrosis fac-
tor alpha (TNF-), interleukins (IL-1, IL-6, IL-12, and IL-18), and
chemokines (IL-8), that amplify the innate and adaptive immune
responses leading to pathogen clearance and resolution of inflam-
mation.
Innate immune cells also can release a number of cytokines
with the capacity to inhibit functions of effector cells and suppress
inflammation. IL-10 is probably the most important anti-inflam-
matory cytokine for limiting the overwhelming immune reactions
that might lead to tissue injury. Mononuclear phagocytes and
lymphocytes represent the main source of IL-10. It is known that
IL-10 inhibits the production of proinflammatory cytokines and
chemokines and reduces the antigen-presenting capacity of anti-
gen-presenting cells (dendritic cells) by downregulating major
histocompatibility complex class II (MHC-II) molecules (18).
On the basis of all this knowledge, the present investigationwas
undertaken to determine the mechanisms that occur, during the
early phase of infection, betweenhumanmonocytes/macrophages
and Acanthamoeba.
To monitor monocyte/macrophage activation, we focused on
the cytokine production by human monocytes isolated from pe-
ripheral blood (PBMCs) and human monocyte-derived macro-
phages (MDMs). THP-1 cells have been used to perform a large
number of experiments, limiting the need for human blood do-
nors.
The present study determines the kinetics of TNF-, IL-6,
IL-8, IL-10, and IL-12 secretion by THP-1 cells (19), PBMCs, and
MDMs in response to Acanthamoeba trophozoites and soluble
products contained in amoebic conditioned cell-free medium
(aCM). We demonstrate that Acanthamoeba stimulates proin-
flammatory cytokine release as well as the early production of
IL-10 in these innate immune cells.
MATERIALS AND METHODS
Reagents and materials. RPMI 1640 medium and fetal calf serum (FCS)
were obtained from Gibco-BRL/Life Technologies, Italy. HEPES buffer,
penicillin G-streptomycin sulfate, Dulbecco’s phosphate-buffered saline
solution (PBS), Histopaque 1077, and Escherichia coli lipopolysaccharide
(LPS) were obtained from Sigma-Aldrich Srl, Milan, Italy. The monoclo-
nal antibody Leu-M3 (anti-CD14) was from Becton Dickinson (San Jose,
CA). Enzyme-linked immunosorbent assay (ELISA) kits (human TNF-
DuoSet, human IL-6 DuoSet, human IL-12 p70 DuoSet, human CXCL8/
IL-8 DuoSet, and human IL-10 DuoSet) were obtained from R&D Sys-
tems (Space Srl, Milan, Italy).
Amoeba culture conditions. Our study was performed using tropho-
zoites ofA. castellanii genotype T4 (20, 21), isolated from the corneal ulcer
of a soft contact lens wearer (in Ancona, Italy) and axenically grown at
25°C in proteose-yeast extract-glucose (PYG) medium (22). Species and
genotype identification of this isolate were based on cyst morphology,
PCR analysis using primers JDP1 and JDP2 (specific for 18S rRNA gene
stretch ASA.S1), and DNA sequencing (23). It is known that Acantham-
oeba can be reservoirs for amoeba-resistant microorganisms such as bac-
teria, fungi, and viruses (24–26). For this reason, PCR with universal
bacterial primers was applied in order to verify the absence of bacteria
within the trophozoites used in the experiments (27), and theywere free of
any contaminants. Our previous observations showed that this A. castel-
lanii isolate was able to damage the human amnion-derived epithelial cell
line (Wish) by both contact-dependent and contact-independent mech-
anisms (22). Amoebae used for the inocula were taken from logarithmic-
phase cultures. In each experiment cell viability was95%, as determined
by the nigrosin dye exclusion method.
Preparation of aCM. Amoeba cell-free conditioned medium (aCM)
was prepared as previously described (20, 22, 28, 29). Briefly, amoebae
were washed twice in PBS (2.7 mM KCl,1.5 mM KH2PO4, 136.9 mM
NaCl, 8.9 mMNa2HPO4 · 7H2O, pH 7.4), suspended (4  10
6 cell/ml) in
RPMI 1640medium containing 20mMHEPES, and finally incubated for
2 h at 25°C. Amoeba cell-free supernatant was obtained by centrifugation
at 500  g for 15 min and used as conditioned medium (aCM) after the
addition of 5%heat-inactivated FCS. For each experiment, aCMwas used
immediately after processing.
Culture conditions of THP-1 cell line. THP-1 cells (Sigma-Aldrich,
Milan, Italy) were maintained in continuous culture in RPMI 1640 me-
dium supplemented with 10% heat-inactivated FCS, 100 U of penicillin
G, and 100 g/ml of streptomycin sulfate and grown in 25-cm2 sterile
plastic flasks at 37°C in a humid atmosphere containing 5% CO2. In each
experiment cell viability was 95%, as determined by the nigrosin dye
exclusion method.
Human monocyte isolation and MDM differentiation. Human ve-
nous whole blood was obtained from three different healthy volunteers at
the Hospital-University Company (AUO-SS, Sassari, Italy), where all of
the relevant ethical reviews and approvals were granted for collection and
manipulation at the time. Donors had taken no medication for at least 2
weeks before they donated blood. Monocytes were isolated from aliquots
of blood (40 ml) as previously described (30). Briefly, blood was diluted
with phosphate-buffered saline (pH 7.4), layered over aHistopaque (den-
sity, 1.077 g/cm3) gradient solution, centrifuged (400  g, 25 min, room
temperature), and recovered by thin suction at the interface. The mono-
nuclear cell layer was washed twice by centrifuging with PBS (200  g, 10
min, room temperature) and then suspended in RPMI 1640 medium
supplemented with 20% heat-inactivated FCS, 2 mM glutamine, 10 mM
HEPES, and antibiotics. Purified PBMCs were obtained by cell adhesion
in 25-cm2 sterile plastic flasks; after 22 h of incubation at 37°C in 5%CO2,
nonadherent cells (mainly lymphocytes) were removed by gentle washes
with PBS. Adherent cells were characterized by immunofluorescence with
the monoclonal antibody LEUm3 (anti-CD14), a marker for the LPS re-
ceptor, that was used to define blood monocytes (31). MDMs were pre-
pared frommonocytes cultured for 8 to 10 days in a 5%CO2 incubator at
37°C in RPMI 1640 medium containing 20% FCS, 2 mM glutamine, 10
mM HEPES, and antibiotics; medium was changed every 2 to 3 days.
MDMs at day 9 were characterized by evaluating the decrease in the sur-
face monocyte marker CD14. PBMCs and MDMs obtained from each
donor were used separately. In each experiment cell viability was 95%,
as determined by the nigrosin dye exclusion test.
Experimental design. Preliminary tests were performed to optimize
the number of target cells (THP-1 cells, human PBMCs, andMDMs) and
trophozoites and the concentration of LPS to apply in the experiments.
Target cell stimulation for the analysis of Acanthamoeba-induced
cytokine production. For each experiment, 0.2 ml of target cell suspen-
sion (2  105 cells) was seeded in 24-well tissue culture plates. Subse-
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quently, 0.8 ml of trophozoite suspension (2.5  104 trophozoites/ml) in
RPMI medium–20 mM HEPES supplemented with 5% FCS (complete
RPMI medium) was added to the wells for the coincubation trophozoite/
target cell condition (amoeba/target cell ratio, 1:10), while the stimulation
with amoebic conditioned cell-freemediumwas performed by adding 0.8
ml of aCM (obtained as described above). Target cells were also incubated
with complete RPMI medium containing E. coli LPS (final concentration
of 10 ng/ml) as a positive control. Complete RPMI medium (0.8 ml) was
added to the wells as a negative-control condition. Plates were incubated
at 37°C in the presence of 5% CO2 throughout the duration of the exper-
iment. At time intervals ranging from 1.5 to 23 h, plates were centrifuged
(200  g for 10 min), and culture supernatants were collected and stored
at 80°C until cytokine production evaluation. Cytokine concentrations
in THP-1 experimental supernatants were evaluated at 1.5, 4, 6, and 23 h
poststimulation, whereas for both PBMCs and MDMs culture superna-
tants were evaluated at 1.5, 3, 5, and 18 h poststimulation.
Measurement of cytokine concentrations by ELISA. The concentra-
tion of each examined cytokine (TNF-, IL-6, IL-8, IL-10, and IL-12) was
measured quantitatively with the use of the relevant kit of the DuoSet
ELISA development system (R&DSystems) according to themanufactur-
er’s instructions. Optical density was measured using a spectrophotome-
ter (Servamax) at a 450-nm wavelength. Cytokine concentration was cal-
culated, based on the values of a standard curve, using the software
SoftMax Pro 5.0.1. Concentrations were expressed in picograms per mil-
liliter.
Statistical analyses. All experiments were performed in triplicate and
were repeated at least three times. Data are presented as the means 
standard errors of the means (SEM). Statistical difference was evaluated
with the two-tailed Student t test and one-way analysis of variance
(ANOVA) followed by Dunnett’s multiple-comparison test using Graph-
Pad Prism, version 5 (GraphPad Software Inc.). P values of 0.05 and
0.01 were considered significant and very significant, respectively.
RESULTS
PBMC and MDM characterization. The great majority of ad-
herent cells (93%  5%, n 	 3) used in our experiments as
PBMCs were CD14
, while a significantly lower percentage of
MDMs (8%  0.95%, n 	 3) were CD14
 at day 9.
A. castellanii (genotype T4) modulates the production of
proinflammatory cytokines (TNF-, IL-6, and IL-12) in human
THP-1 cells, monocytes, and macrophages in a time-dependent
manner. (i) TNF-. At 1.5 h postinfection, significant TNF-
production was detected in THP-1 cultures stimulated with aCM
(82.55 0.8776 pg/ml, n 	 5,P  0.0001) and LPS (20.88 5.144
pg/ml, n 	 5, P  0.005) compared with noninfected controls,
showing significant levels throughout the course of the stimula-
tion. Of interest, aCM elicited a biphasic release curve, character-
ized first by a rapid increase at 1.5 h and then a second peak
(57.1433  3.681 pg/ml, n 	 5, P  0.0001) at 6 h (Fig. 1A).
Coincubation of THP-1 with trophozoites caused a significant
increase of TNF-, which peaked at 4 h (130.747  8.689 pg/ml,
n 	 5, P  0.0001) and then decreased drastically (Fig. 1A). A
TNF- concentration of 10 pg/ml was detected in control
THP-1 cells at all times (Fig. 1A).
TNF- production in human PBMCs was significantly in-
duced by aCM throughout the time course, in particular peaking
at 18 h poststimulation (328.521  47.84 pg/ml, n 	 3, P 
0.0001) (Fig. 1B). On the contrary, coincubation of human
PBMCs with trophozoites showed a significant increase of TNF-
only after 3 h of coincubation, reaching the highest value at 5 h
(93.66  2.993 pg/ml, n 	 3, P  0.0001) and subsequently re-
maining constant (Fig. 1B).
A basal TNF- concentration of 25 pg/ml was detected in
nonstimulated human MDMs and in MDM cultures either stim-
ulated with aCM or coincubated with trophozoites at any time. In
contrast, the treatment with LPS caused significant production of
TNF- by these cells, peaking at 18 h poststimulation (Fig. 1C).
(ii) IL-6. aCM-stimulated THP-1 produced IL-6 throughout
the course of the stimulation. In particular, IL-6 was significantly
released after 1.5 h poststimulation (13.354 0.796 pg/ml, n 	 5,
P  0.0001), peaking at 4 h (18.85  0.03395 pg/ml, n 	 5, P 
0.0001) and subsequently decreasing until 23 h, still showing sig-
nificant concentration values (8.000  0.5774 pg/ml, n 	 5, P 
0.0001). In contrast, coincubation with trophozoites did not in-
duce release of IL-6 by THP-1. LPS-induced IL-6 production
reached higher values after 23 h poststimulation (6.773 0.01368
pg/ml, n 	 5, P  0.0001). Interestingly, the dynamics and profile
FIG 1 TNF- production by THP-1 (A), PBMCs (B), and MDMs (C) after
coincubation with trophozoites of A. castellanii (trophozoites) or stimulation
with aCM. A total of 2  105 of either target cells were challenged with either
2 104 trophozoites at a ratio of 10:1 or with 800l of aCM (final dilution, 4:5
in the culture medium). TNF- concentration in THP-1 experimental super-
natants was evaluated at 1.5, 4, 6, and 23 h poststimulation, whereas in both
PBMC and MDM experimental supernatants it was evaluated at 1.5, 3, 5, and
18 h poststimulation. All three cellular models were stimulated with 10 ng/ml
LPS as a positive control (LPS), whereas unstimulated cells (control) were
considered the negative control. Experiments were performed in triplicate and
repeated at least 3 times. Results represent the mean values  SEM of either
n 	 5 (THP-1) or n 	 3 (PBMCs andMDMs) samples. One-way ANOVAwas
applied for each time point. Dunnett’s multiple-comparison test was per-
formed to evaluate differences between the experimental conditionmeans and
the control at each time point. In the graphs, significance between the experi-
mental conditions and the control are indicated as P values of 0.05 (*),
0.005 (**), and0.0001 (***). On the right, the same results are expressed as
fold change (FC) over the unstimulated cells.
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of aCM-induced IL-6 production in THP-1 cells was quite dissim-
ilar from that induced by LPS stimulation. In fact, aCM caused a
significantly more rapid IL-6 production than LPS that peaked at
23 h poststimulation. IL-6 was not detectable in control THP-1
culture supernatants at any time (Fig. 2A).
PBMC stimulation with aCM induced a significant time-de-
pendent release of IL-6 throughout the time course, reaching the
highest value at 18 h poststimulation (602.0 8.145 pg/ml, n 	 3,
P  0.0001) (Fig. 2B). LPS-induced IL-6 production in this cellu-
larmodel peaked at 5 h poststimulation (615.0 13.28 pg/ml, n 	
3, P  0.0001) (Fig. 2B). Human PBMCs coincubated with tro-
phozoites produced an increase of IL-6 from 5 h to 18 h postin-
fection (17.1612  0.9115 pg/ml, n 	 3), and this release was
significant compared to the control (0.1  0.05774 pg/ml, n 	 3)
only through the evaluation by Student t test (P  0.0001)
(Fig. 2B).
HumanMDMs coincubated with trophozoites, as well as con-
trolMDMcultures, did not release IL-6, whereas stimulation with
aCM induced a significant increase of IL-6 concentration during
the time course with a pattern similar to that seen in THP-1 cells,
characterized by a rapid and early peak at 1.5 h (61.56  0.7817
pg/ml, n 	 3, P  0.0001), followed by a slow and gradual
reduction. On the contrary, LPS peaked at 18 h poststimulation
(66.56  2.105 pg/ml, n 	 3, P  0.0001) (Fig. 2C).
(iii) IL-12. IL-12 production increased progressively through-
out the course of the experiment in aCM-stimulated THP-1 cells,
human PBMCs, and MDMs, reaching the highest concentrations
at 1.5 h postinfection compared with the respective control cul-
tures. The IL-12 concentrations detected in THP-1 cells (23.78 
1.810 pg/ml, n 	 5, P  0.0001) were lower than those measured
in PBMCs (77.44  2.782 pg/ml, n 	 3, P  0.0001) and MDMs
(63.34  1.744 pg/ml, n 	 3, P  0.0001) (Fig. 3).
CoincubationwithAcanthamoeba trophozoites did not induce
IL-12 production by PBMCs and MDMs. Of interest, in the
THP-1 culture a significant increase of IL-12 concentration was
detected compared to the negative control (5.883 0.001333, n 	
5, P  0.0001 by Student t test) at 1.5 h postcoincubation with
trophozoites, followed by a significant decrease at 4 h (1.220 
0.00014 pg/ml, n 	 5, P  0.05) and 6 h (2.853  0.0013 pg/ml,
n 	 5, P  0.05) postcoincubation (Fig. 3A).
LPS stimulation did not induce any significant effect in the
release of IL-12 by PBMCs andMDMs, whereas in THP-1 cells we
observed a pattern similar to that induced by trophozoites (Fig. 3).
A. castellanii (genotype T4) modulated the production of
inflammatory chemokine IL-8 in human THP-1 cells, mono-
cytes, and macrophages in a time-dependent manner. IL-8 pro-
duction by THP-1 cells was rapidly induced after coincubation
withAcanthamoeba trophozoites, reaching the highest value at 4 h
postincubation (920.7  10.04, n 	 5, P  0.0001) and rapidly
declining after, similar to the release pattern of TNF- under
the same experimental conditions. In contrast, aCM-induced
IL-8 production by THP-1 was lower, reaching its highest val-
ues at 23 h poststimulation (213.2  3.424 pg/ml, n 	 5, P 
0.005) (Fig. 4A).
IL-8 production by human PBMCs was induced by both Acan-
thamoeba trophozoites and aCM from the earliest time point (1.5 h)
and reached its highest values at 5 h poststimulation (Fig. 4B).
In human MDMs, both coincubation with trophozoites and
aCM stimulation caused an immediate decrease of IL-8 concen-
tration compared to control MDM cultures. Specifically, at 1.5 h
postinfection the following values were detected: 201.3  6.387
pg/ml, n 	 3; 339.1  7.734 pg/ml, n 	 3; and 424.1  17.95
pg/ml, n 	 3 (Fig. 4C). The inhibitory effect induced by tropho-
zoites was observed throughout the time course, whereas aCM
induced a transient inhibitory effect, since IL-8 production in-
creased by significant values between 5 and 18 h poststimulation
(Fig. 4C).
LPS stimulation induced a significant release of IL-8 by THP-1
and PBMCs from the earliest time point (1.5 h), reaching the
highest values at 5 h poststimulation, whereas in MDMs it caused
FIG 2 IL-6 production by THP-1 (A), PBMCs (B), and MDMs (C) after
coincubation with trophozoites of A. castellanii (trophozoites) or stimulation
with aCM. A total of 2  105 of either target cells were challenged with either
2 104 trophozoites, ratio of 10:1, or with 800l of aCM (final dilution of 4:5
in the culture medium). IL-6 concentration in THP-1 experimental superna-
tants was evaluated at 1.5, 4, 6, and 23 h poststimulation, whereas in both
PBMC and MDM experimental supernatants it was evaluated at 1.5, 3, 5, and
18 h poststimulation. All three cellular models were stimulated with 10 ng/ml
LPS as a positive control, whereas unstimulated cells (control)were considered
the negative control. Experiments were performed in triplicate and repeated at
least 3 times. Results represent themean values SEMof eithern 	 5 (THP-1)
or n 	 3 (PBMCs and MDMs) samples. One-way ANOVA was applied for
each time point. Dunnett’s multiple-comparison test was performed to eval-
uate differences between the experimental condition means and the control at
each time point. In the graphs, significances between the experimental condi-
tions and the control are indicated as a P value of0.0001 (***). Student t test
was also applied at each time point to verify the significance of single pairs of
means (single experimental condition versus control). In the graphs, signifi-
cance between the experimental condition and the control, obtained with Stu-
dent t test, are indicated as P values of 0.005 (**) and 0.0001 (***). On the
right, the same results are expressed as fold change (FC) over the unstimulated
cells.
Mattana et al.
2956 iai.asm.org October 2016 Volume 84 Number 10Infection and Immunity
a significant decrease of IL-8 concentration at 1.5 h, followed by a
significant increase that reached a maximum peak at 5 h post-
stimulation (Fig. 4).
A. castellanii (genotype T4) stimulated the production of
anti-inflammatory cytokine IL-10 in human THP-1 cells, mono-
cytes, and macrophages in a time-dependent manner. IL-10pro-
duction by all three cellular models was significantly induced by
aCM compared with the control. Coincubation with Acantham-
oeba trophozoites also produced a significant release of IL-10 in
THP-1 cells and PBMCs. IL-10 levels in supernatants from un-
stimulated THP-1 cells and MDMs ranged between 0.82 and 1.47
pg/ml and between 22.02 and 30.15 pg/ml, respectively. IL-10 was
not detectable in nontreated PBMCs cultures at any time (Fig. 5).
IL-10 production by all three cellular models following aCM
stimulation showed a similar pattern, characterized by a peak at
1.5 h poststimulation (THP-1 cells, 584.0  46.58 pg/ml, n 	 5,
P  0.0001; PBMCs, 883.30  23.69 pg/ml, n 	 3, P  0.0001;
MDMs, 574.4 15.07 pg/ml, n 	 3, P  0.0001), a plateau (up to
3 to 4 h), and a slow decline, maintaining significant values
throughout the course of stimulation. The infection with Acan-
thamoeba trophozoites evoked a transient increase of IL-10 con-
centration by THP-1 cells that was significant only at 1.5 h postin-
FIG 3 IL-12 production by THP-1 (A), PBMCs (B), and MDMs (C) after coin-
cubation with trophozoites of A. castellanii (trophozoites) or stimulation with
aCM. A total of 2  105 of either target cells were challenged with either 2  104
trophozoites, ratio of 10:1, or with 800 l of aCM (final dilution of 4:5 in the
culture medium). IL-12 concentration in THP-1 experimental supernatants was
evaluated at 1.5, 4, 6, and 23 h poststimulation, whereas in both PBMCs and
MDMsexperimental supernatants itwas evaluatedat 1.5, 3, 5, and18hpoststimu-
lation. All three cellular models were stimulated with 10 ng/ml LPS as a positive
control, whereas unstimulated cells (control) were considered the negative con-
trol.Experimentswereperformed in triplicateandrepeatedat least3 times.Results
represent themean values SEMof either n 	 5 (THP-1) or n 	 3 (PBMCs and
MDMs) samples. One-way ANOVA was applied for each time points. Dunnett’s
multiple-comparison test was performed to evaluate differences between the ex-
perimental condition means and the control at each time point. In the graphs,
significance between the experimental conditions and the control are indicated as
P values of 0.05 (*), 0.005 (**), and 0.0001 (***). Student t test was also
applied at each time point to verify the significance of single pairs ofmeans (single
experimental condition versus control). In the graphs, significances between the
experimental conditionand the control, obtainedwithStudent t test, are indicated
as a P value of 0.0001 (***). On the right, the same results are expressed as fold
change (FC) over the unstimulated cells.
FIG 4 IL-8 production by THP-1 (A), PBMCs (B), and MDMs (C) after
coincubation with trophozoites of A. castellanii (trophozoites) or stimulation
with aCM. A total of 2  105 of either target cells were challenged with either
2 104 trophozoites, ratio of 10:1, or with 800l of aCM (final dilution of 4:5
in the culture medium). IL-8 concentration in THP-1 experimental superna-
tants was evaluated at 1.5, 4, 6, and 23 h poststimulation, whereas in both
PBMCs andMDMs experimental supernatants it was evaluated at 1.5, 3, 5, and
18 h poststimulation. All three cellular models were stimulated with 10 ng/ml
LPS as a positive control, whereas unstimulated cells (control)were considered
the negative control. Experiments were performed in triplicate and repeated at
least 3 times. Results represent themean values SEMof eithern 	 5 (THP-1)
or n 	 3 (PBMCs and MDMs) samples. One-way ANOVA was applied for
each time points. Dunnett’s multiple-comparison test was performed to eval-
uate differences between the experimental condition means and the control at
each time point. In the graphs, significances between the experimental condi-
tions and the control are indicated as P values of 0.05 (*), 0.005 (**), and
0.0001 (***). Student t test was also applied at each time point to verify the
significance of single pairs of means (single experimental condition versus
control). In the graphs, significances between the experimental condition and
the control, obtained with Student t test, are indicated as a P value of 0.0001
(***). On the right, the same results are expressed as fold change (FC) over the
unstimulated cells.
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fection (P value of 0.0001 by Student t test), whereas in PBMCs
it was significant at both 1.5 and 3 h poststimulation (P value of
0.05 by Student t test) (Fig. 5A and B).
In all three cellularmodels examined, LPS stimulation induced
a delayed and gradual IL-10 production compared to Acantham-
oeba stimulation (Fig. 5).
Cytokine and chemokine release patterns induced by either
aCMor trophozoites in all three cellular models, presented as fold
change (FC) over unstimulated cells, are summarized in Fig. 6 and
7, respectively.
DISCUSSION
In vivo and in vitro studies suggest that both humoral and cell-
mediated adaptive immune responses are induced by Acantham-
oeba, although they are not efficient in resolving the infection
(32–35). Consequently, it is the general consensus that the innate
immune response plays the main role in preventing the establish-
ment of Acanthamoeba infections and is responsible for the clear-
ance of the amoebae from host tissues (16, 36). Little is known
about the interactions between Acanthamoeba and monocytes/
macrophages in in vitro human models and, in particular, the
pattern of proinflammatory and anti-inflammatory cytokines that
both whole trophozoites and amoeba-released products induce.
Our study indicates that human monocytes and human mac-
rophages can recognize and respond to Acanthamoeba trophozo-
ites as well as to amoebic soluble compounds, releasing cytokines
and chemokines with different kinetics and intensity. The present
findings, therefore, suggest that amoeba adhesion to these cells is
not a prerequisite to induce their response to Acanthamoeba.
In particular, our data show that whole trophozoites and
amoebic products are capable of inducing a different response by
the target cell types, with the latter being more effective in stimu-
lating all cytokines (TNF-, IL-6, IL-12, and IL-10) and the
chemokine (IL-8) investigated. The effect of the trophozoites ap-
pears to be more complex, since they can both stimulate and in-
hibit cytokine production. Indeed, they induce IL-10, IL-6 (only
by PBMCs), TNF-, and IL-8 release in monocytes, but they in-
hibit the production of TNF- and IL-8 bymacrophages. Tropho-
zoites do not exert any effect on the production of IL-12 by
PBMCs andMDMs, while in THP-1 cells theymodulate its release
both in a positive and negative way.
In our opinion, the different cytokine patterns induced by ei-
ther trophozoites or aCMmay be due, in part, to the actual com-
position of the aCM. In accordancewith our previous studies (22),
aCM contains the released products of a number of trophozoites
at 160 times higher than the number of trophozoites actually used
for the trophozoite/target cell coincubationmodels. In fact, it was
not possible to use trophozoite/target cell ratios greater than 1:10,
since a higher number of trophozoites induced lower cytokine
production and caused a cytopathic effect. Nevertheless, our data
do not preclude the possibility that these differences are specific to
products secreted by trophozoites.
The response of monocytes and macrophages to Acantham-
oeba showed differences, probably due to a different expression of
receptors and coreceptors following cell differentiation. In this
regard, we exclude the significant interference of individual fac-
tors, as the data obtained bymonocytes andmacrophages isolated
from different blood donors showed a remarkable homogeneity.
Moreover, the results obtained from the characterization of
monocytes andmacrophages before each experiment indicate that
cell populations used in our experiments were homogeneous. We
suggest that the responsiveness of target cells varied according to
the following order: PBMCs  THP-1  MDMs.
THP-1 cells are a human leukemia monocytic cell line exten-
sively used to study the modulation of monocytes and macro-
phages during infectious conditions without using human blood
samples (37). THP-1 cells in the monocyte state can be differen-
tiated into amacrophage-like phenotype using either phorbol-12-
myristate-13-acetate (PMA) or 1,25 dihydroxyvitamin D3
(vD3) (38, 39). Our data indicate that THP-1 cells are a good
FIG 5 IL-10 production by THP-1 (A), PBMCs (B), and MDMs (C) after
coincubation with trophozoites of A. castellanii (trophozoites) or stimulation
with aCM. A total of 2  105 of either target cells were challenged with either
2 104 trophozoites, ratio of 10:1, or with 800l of aCM (final dilution of 4:5
in the culturemedium). IL-10 concentration in THP-1 experimental superna-
tants was evaluated at 1.5, 4, 6, and 23 h poststimulation, whereas in both
PBMCs andMDMs experimental supernatants it was evaluated at 1.5, 3, 5, and
18 h poststimulation. All three cellular models were stimulated with 10 ng/ml
LPS as a positive control, whereas unstimulated cells (control)were considered
the negative control. Experiments were performed in triplicate and repeated at
least 3 times. Results represent themean values SEMof eithern 	 5 (THP-1)
or n 	 3 (PBMCs and MDMs) samples. One-way ANOVA was applied for
each time points. Dunnett’s multiple-comparison test was performed to eval-
uate differences between the experimental condition means and the control at
each time point. In the graphs, significance between the experimental condi-
tions and the control are indicated as P values of 0.05 (*), 0.005 (**), and
0.0001 (***). Student t test was also applied at each time point to verify the
significance of single pairs of means (single experimental condition versus
control). In the graphs, significance between the experimental condition and
the control, obtained with Student t test, are indicated as P values of0.05 (*)
and 0.0001 (***). On the right, the same results are expressed as fold change
(FC) over the unstimulated cells.
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experimental model for the study of Acanthamoeba interactions
with human monocyte/macrophage. Interestingly, although our
experiments have been conducted onTHP-1 cells not subjected to
any previous activation, we found that their behavior regarding
the release of IL-6wasmore similar to that ofMDMs thanPBMCs.
Indeed, the dynamics and profile of aCM-induced IL-6 produc-
tion by THP-1 cells and MDMs were quite dissimilar from those
induced by LPS stimulation. Moreover, aCM caused significantly
more rapid IL-6 production than stimulation with LPS. However,
in PBMCs, following aCM stimulation, IL-6 release showed a
trend similar to that obtained by LPS stimulation. In addition,
Acanthamoeba trophozoites failed to induce IL-6 production in
both THP-1 cells and MDMs. This diversity observed in the re-
sponsiveness of PBMCs and THP-1 cells lead us to hypothesize
that the latter are differentiating from amonocytic toward a mac-
rophagic stage.
IL-10 is now considered a key regulator of innate immunity,
and it is known to suppress inflammation and macrophage activ-
ity by inhibiting the production of gamma interferon (IFN-),
IL-2, IL-12, IL-18, and TNF-, as well as other cytokines (18, 40,
41); nevertheless, the molecular mechanisms underlying the sig-
naling events that lead to IL-10 anti-inflammatory actions are not
entirely clear. To our knowledge, this is the first report demon-
strating that Acanthamoeba trophozoites can induce the produc-
tion of IL-10, a potent immunosuppressive and anti-inflamma-
tory cytokine, by human mononuclear cells in vitro. Similarly,
aCM can also induce IL-10 production, although showing greater
concentration than that with trophozoites. Specifically, we ob-
served that Acanthamoeba induced an early production of IL-10
by both humanmonocytes (THP-1 cells and PBMCs) andMDMs,
reaching its peak after just 1.5 h poststimulation and maintaining
high levels up to 18 h postinfection. These data are very important,
since the early phase of infection is the key step where an inflam-
matory, regulatory, and/or memory response is preferentially in-
duced. In terms of timing, this is the moment in which IL-10 can
radically influence subsequent responses (42, 43). Indeed, it has
been demonstrated that the early production of IL-10 can lead to
a premature change from cell-mediated immunity to humoral
adaptive responses, causing persistent or chronic infection (44).
We hypothesize that the release of IL-10 is due to the activity of a
soluble molecule(s) secreted by Acanthamoeba. At the moment,
the chemical nature of this molecule(s) has not been character-
ized; however, studies for its identification and characterization
have already being designed. Numerous recent studies have dem-
onstrated that IL-10 is triggered by Leishmania spp., Plasmodium
spp.,Toxoplasma gondii, andTrypanosoma spp.However, the spe-
cific protozoan components and the mechanisms involved in this
immune event are still unclear (45).
Our previous study on the effects caused by Acanthamoeba-
released products on THP-1 cells has shown that coincubation
with aCM induces production of IL-6, while heat treatment (95°C
for 10 min) and aCM fractionation (using Centriprep-30 and
Centriprep-10 microconcentrators with 30- and 10-kDa cutoffs,
respectively) abolishes its activity (29). These data were confirmed
and broadened by our present study, where we showed the ability
of aCM to induce remarkable levels of IL-6, which reaches its
highest peak much earlier in THP-1 cells and MDMs than in
PBMCs. At the moment, we cannot establish whether IL-6 release
FIG 6 Schematic summary of the cytokines released by THP-1 (A), human PBMCs (B), and human MDMs (C) after stimulation with aCM. Incubation with
aCM induced the release of a greater number of cytokines. In particular, IL-10, IL-6, and IL-12 were immediately produced, by both humanmonocytes (THP-1
cells and PBMCs) and human macrophages, and detected throughout the period of stimulation. Their increase was constant overall during the course of
observations. aCM induced TNF- production only by monocytes, although showing a different release pattern: its concentration increased in PBMCs during
the time course (FC of 4.69 to 11.69), whereas in THP-1 cells it decreased (FC of 4.29 to 0.64). aCM-induced IL-8 production increased (FC of 1) at 5 to 6 h
poststimulation (THP-1 and PBMCs) or at 18 h poststimulation (MDMs).
FIG 7 Schematic summary of the cytokines released by THP-1 cells (A), human PBMCs (B), and human MDMs (C) after coincubation with Acanthamoeba
trophozoites. During coincubation with trophozoites of Acanthamoeba, human monocytes (THP-1 cells and PBMCs) produced IL-10 from the earliest time
points only for a short period of time; subsequently it produced TNF- and IL-8. In contrast, trophozoites induced a particular decrease of IL-8 and TNF- in
human macrophages.
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is induced directly by amoebic metabolite stimulation or indi-
rectly by the autocrine action of IL-10 (considering its increasing
concentration in the culture medium), or again if it depends on
both these causes. In fact, it is known that IL-10 can moderate
infection-associated immune pathology linked with strong Th1
responses (46). The suppressive activity of IL-10 toward Th1 re-
sponses enables the development of Th2 responses characterized
by the production of IL-6 (18, 41). IL-6 acts during early and late
innate immune events; indeed, it damps the early innate immune
responses by inducing neutrophil apoptosis and the production of
IL-1 and TNF- antagonists, initiating the late innate immune
events, such as the recruitment of monocytes and their differenti-
ation into macrophages. Subsequently, IL-6 promotes antibody
production by B lymphocytes. Although this effect on humoral
effector mechanisms related to B lymphocytes is important in the
resolution of some helminthic and protozoan infections, it is in-
effective in resolving other infections, such as those caused by
Plasmodium and Acanthamoeba (47, 48).
It is known that TNF- is an early cytokine rapidly released by
monocytes andmacrophages to activate neutrophils and endothe-
lial cells (49). It has also been shown that Acanthamoeba spp. are
not susceptible to killing by TNF- and that this cytolytic factor,
which promptly induces trophozoite encystment, may paradoxi-
cally offer protection frommacrophage phagocytosis (17). A. cas-
tellanii trophozoites and aCM induced various levels of TNF- in
humanmonocytes (THP-1 cells andPBMCs), but despite the abil-
ity to produce this potent proinflammatory cytokine being in-
cluded in the antimicrobial arsenal of macrophages, both tropho-
zoites and aCM failed to induce TNF- in human macrophages.
However, treatment with LPS caused a significant release of
TNF- by humanmacrophages, indicating that, under our exper-
imental conditions, they had the potential to produce this cyto-
kine. Furthermore, the aCM-mediated TNF- production ob-
served in monocytes confirms our previous findings obtained in
THP-1 cells (29). Interestingly, comparing the release curves of
TNF- and IL-10 in THP-1 cells and PBMCs after stimulation
with either LPS or Acanthamoeba, it is clear that LPS causes early
production of TNF- but delayed IL-10 production, underlying a
correlation between the two cytokines: as the latter increases, the
concentration of TNF- decreases. Interestingly, both Acantham-
oeba trophozoites and aCM stimulate a peculiar early release of
both cytokines, but in this case we also can observe a clear corre-
lation between the increase of IL-10 and decrease of TNF-.
IL-12 is a proinflammatory cytokine that induces phagocyte
cytotoxic activity, the production of reactive nitrogen species
(RNS) and reactive oxygen species (ROS), and the stimulation of
IFN- by natural killer (NK) cells, cytotoxic T lymphocyte (CTL)
development, and/or Thl lymphocyte responses (50).We also ob-
served that aCM, in contrast to trophozoites, causes IL-12 release
in human THP-1 cells, PBMCs, and MDMs for the whole dura-
tion of the observations, albeit of low intensity.
Monocytes/macrophages recruit neutrophils and other granu-
locytes to the site of infection through the release of IL-8 that, in
target cells, induces a series of physiological responses required for
migration and phagocytosis, such as an increase in intracellular
Ca2
, exocytosis, and the respiratory burst (51). In vivo studies
using animal models have demonstrated that neutrophils are re-
cruited following corneal trauma associated with Acanthamoeba
infections and that they are present in granulomas in the brain,
preventing the spread of the protozoan (14, 16, 52). In this con-
text, we found that Acanthamoeba can indirectly modulate the
recruitment and activity of neutrophils, since both trophozoites
and aCM stimulate the production of IL-8 by human monocytes,
although of low intensity. On the other hand, only aCM induces
the release of IL-8 by human macrophages, whereas trophozoites
cause a significant decrease of this chemokine compared to non-
infected cultures.
Taken together, our findings indicate that challengewithAcan-
thamoeba or their soluble products can upregulate both proin-
flammatory cytokines (TNF-, IL-6, and IL-12) and anti-inflam-
matory cytokine (IL-10), suggesting that this protozoan infection
results from the early induction of the concurrent conflicting im-
mune responses. Humanmonocytes, compared to monocyte-de-
rived macrophages, have a greater responsiveness toward these
amoebae, especially toward trophozoites, by releasing both cyto-
kines and the chemokine IL-8. Therefore, we suggest that mono-
cytes are involved in preventing the hematogenous spread of
Acanthamoeba trophozoites rather than directly acting at sites of
infection.
In conclusion, results reported in this paper confirm that the
production of proinflammatory cytokines and chemokines by
monocytes and macrophages can play a role in the inflammatory
response during Acanthamoeba infections. Moreover, they dem-
onstrate for the first time that Acanthamoeba stimulates the pro-
duction of IL-10 in human innate immune cells. This anti-inflam-
matory cytokinemight play a role in both promoting the immune
evasion of Acanthamoeba and limiting the induced inflammatory
response.
Further in vitro studies are in progress to identify the nature of
amoebic surface molecules and of the secreted products which
stimulate cytokine and chemokine release by monocytes/macro-
phages, as well as to evaluate the role of innate immune receptors
and/or coreceptors in the interactions that occur between patho-
genic Acanthamoeba and mononuclear immune cells. Under-
standing the immunological mechanisms involved in host resis-
tance will hopefully provide useful new insights for the
development of effective pharmaceutical treatments for Acan-
thamoeba infections.
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